Datasetspublic full text
ClinicalTrials.gov
clinicaltrials · Datasets · License: Public Domain
178,442Documents
1,450Full text
2026-09-30Last indexed
Recent documents from this source
- Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru#148559
- Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age#148558
- A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers#148557
- Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians#148556
- Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes#148555
- Effect of Oral Supplements for Influenza Vaccine Response#148554
- Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)#148553
- ETEC Logistics Trial (TREK)#148552
- Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia#148551
- Safety and Effectiveness of a Seasonal Live Attenuated Influenza Vaccine in a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like Virus#148550
- Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis#148549
- Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)#148548
- Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults#148547
- Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1#146480
- QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA#146479
- Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)#146478
- Study of hA20 (Humanized Anti-CD20) in Patients With CD20+ Non-Hodgkin's Lymphoma#146477
- Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas#146476
- Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer#146475
- Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity#146474
Source record · clinicaltrials · Datasets · License: Public Domain
Conceptio Open Knowledge Archive — counts are materialised per sync from the index (real full-text coverage, never license entitlement).